Celgene Corporation (CELG) Prices $1.5 Billion of Senior Unsecured Notes
8/2/2013 9:33:07 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced the successful pricing of three series of senior unsecured notes for an aggregate principal amount of $1,500 million. Of these notes, $400 million will mature in 2018 and will bear interest at an annual rate of 2.300%; $700 million will mature in 2023 and will bear interest at an annual rate of 4.000% and $400 million will mature in 2043 and will bear interest at an annual rate of 5.250%. The 2.300% notes due 2018, the 4.000% notes due 2023 and the 5.250% notes due in 2043 were priced to yield 2.344%, 4.067% and 5.307%, respectively.
Help employers find you! Check out all the jobs and post your resume.
comments powered by